AdvisorShares

AlphaNooner by AdvisorShares

Business EN ↓ 93 episodes

The AlphaNooner podcast delivers sharp, educational insights from top industry leaders across finance, policy, and innovation. Each episode dives into timely topics with real-world relevance, designed to inform and empower professionals and curious minds alike. Whether you're a seasoned investor or just getting started, AlphaNooner brings the lessons, context, and clarity you need—always served fresh at noon. Tune in and level up.

Author

AdvisorShares

Category

Business

Latest episode

Jun 24, 2026

Where to listen?

Podcasts in the app Replaio Radio Coming soon

Podcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts

Get it on Google Play Install for free Android 5M+ downloads · 4.8 rating iOS soon

Episodes

AlphaNooner - The Themes Investors Can't Ignore Right Now with Dan Ahrens 24.06.2026

Dan Ahrens joins the AlphaNooner to discuss the themes shaping markets right now, from cannabis uplistings and industry consolidation to psychedelic healthcare breakthroughs, AI infrastructure, industrials, and where capital is flowing. We'll explore what's changing beneath the surface, which trends may have staying power, and what investors should be watching in the second half of 2026.

AlphaNooner - The Cannabis M&A Wave Is Here with Sammy Armenia 22.06.2026

Sammy Armenia, VP of Corporate Development at C21 Investments,  joins Mackenzie Peterson to discuss C21's planned transaction with Vireo Growth, why consolidation is accelerating across cannabis, and what the next generation of industry leaders may look like. Are we entering a new era where scale, capital access, and operational depth matter more than ever? Which markets are becoming most strategi...

#AlphaNooner - The Next Phase of Cannabis: Sam Brill on Growth, Competition, and Opportunity 29.05.2026
AlphaNooner - Dr. Dana Lambert on Andira and the Future of Cannabinoid Healthcare 28.05.2026
#AlphaNooner - Mid-Week Check-In: The Charts Worth Watching 27.05.2026
#AlphaNooner - The Market's Next Big Themes: Dan Ahrens on Where Investors Are Looking Now 26.05.2026
#AlphaNooner - Roundup Weekly: What Mattered in Markets 22.05.2026
#AlphaNooner - What Does Risk Management Mean in 2026? 21.05.2026
#AlphaNooner - Loren DeFalco on Cannabis Research and the Post-Rescheduling Market 20.05.2026
#AlphaNooner - Dan Ahrens on the Market's Most Important Themes Right Now 19.05.2026
#AlphaNooner - Joe Saluzzi on HFT and the Evolution of Modern Markets 18.05.2026
#AlphaNooner - Rubicon Organics Earnings Special with Margaret Brodie 15.05.2026
#AlphaNooner - Eddy Elfenbein on Earnings, Inflation, and Stock Selection 14.05.2026
#AlphaNooner - Hirsh Jain on the Next Phase of Cannabis Investing 13.05.2026
#AlphaNooner - What Earnings Are Revealing About the Themes Leading This Market with Dan Ahrens 12.05.2026
#AlphaNooner - The Week Ahead in Markets 11.05.2026
#AlphaNooner - Buybacks and the Insider Edge: Minyi Chen on What Matters 08.05.2026
#AlphaNooner - $ATAI's Christian Angermayer on the Next Phase of Psychedelics in 2026 07.05.2026
#AlphaNooner - Todd Harrison on the Next Phase of Cannabis Investing 06.05.2026
#AlphaNooner - Earnings and What's Driving Thematic Markets Now with Dan Ahrens 05.05.2026
#AlphaNooner - CEO Eric Offenberger on the Post-Rescheduling Playbook for Vext Science 01.05.2026
#AlphaNooner - Rubicon CEO on Premium Brands, UK, Cascadia Ramp $ROMJ $ROMJF 30.04.2026
#AlphaNooner - Rethinking Balanced Portfolios with CreativeOne's 21st Century Approach 29.04.2026
#AlphaNooner - Ibogaine in the Oval Office: Whiz Buckley on Healing Our Heroes 28.04.2026
#AlphaNooner - Noah Hamman on the Week That Changed Cannabis and Psychedelics 24.04.2026

Listen to the AlphaNooner by AdvisorShares podcast in Replaio

Radio and podcasts in one app - free, with no sign-up. Install today and do not miss the launch

Get it on Google Play

Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.